This invention relates to a class of novel 4H-pyrimido[2,1-a]isoquinoline derivatives. The invention further relates to pharmaceutical compositions containing such 4H-pyrimido[2,1-a]isoquinoline-4-one derivatives and to the use of such compounds and compositions as anorectic agents. In particular, the novel 4H-pyrimido[2,1-a]isoquinoline-4-one derivatives are effective anorectic agents when administered orally.
本发明涉及一类新型的4H-
嘧啶并[2,1-a]
异喹啉衍
生物。本发明还涉及含有这种4H-
嘧啶并[2,1-a]
异喹啉-4-酮衍
生物的制药组合物以及将这些化合物和组合物用作抑食剂。特别地,当口服时,这些新型的4H-
嘧啶并[2,1-a]
异喹啉-4-酮衍
生物是有效的抑食剂。